This inventor holds 2 USPTO granted patents. Top assignees: University of California, The United States Government as Represented by the Department of Veterans Affairs. Active years: 2015-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- San Francisco, CA (US) (2015)
- Burlingame, CA (US) (2016)
Company Filing History:


Years Active: 2015-2016
Title: Yerem Yeghiazarians: Innovator in Cardiovascular Research
Introduction
Yerem Yeghiazarians is a prominent inventor based in Burlingame, CA (US). He has made significant contributions to the field of cardiovascular research, holding 2 patents that focus on innovative methods and compositions for treating cardiovascular diseases. His work has the potential to impact the lives of many individuals suffering from heart-related conditions.
Latest Patents
Yeghiazarians' latest patents include "Cardiosphere derived cell population and methods of use" and "Use of interleukin-15 to treat cardiovascular diseases." The first patent provides compositions and methods for isolating and culturing cardiac progenitor cells, which can lead to improved transplantation techniques. The second patent relates to methods and compositions for treating cardiovascular diseases through the administration of interleukin-15, either alone or in conjunction with other therapeutic agents.
Career Highlights
Throughout his career, Yeghiazarians has worked with esteemed institutions such as the University of California and the United States Government, represented by the Department of Veterans Affairs. His experience in these organizations has allowed him to develop and refine his innovative approaches to cardiovascular treatment.
Collaborations
Some of his notable coworkers include Andrew Boyle and Jianqin Ye. Their collaborative efforts have contributed to the advancement of research in the field of cardiovascular health.
Conclusion
Yerem Yeghiazarians is a dedicated inventor whose work in cardiovascular research is paving the way for new treatment options. His patents reflect a commitment to improving patient outcomes and advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile